2013 Catecholamines Gordon Research Conference and Gordon Research Seminar
2013年儿茶酚胺戈登研究会议暨戈登研究研讨会
基本信息
- 批准号:8593885
- 负责人:
- 金额:$ 2.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-15 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAnimal Disease ModelsAttention deficit hyperactivity disorderBehaviorBehavioralBipolar DisorderCardiovascular DiseasesCatecholaminesCognitionDecision MakingDevelopmentDisciplineDiseaseDopamineDrug AddictionEconomicsEnsureEpinephrineEquilibriumEvaluationFertilizationFosteringFunctional disorderFundingFuture GenerationsGenderGoalsHumanLeadLengthMental DepressionMinorityMolecularMood DisordersMoodsMotorNeuraxisNeurobiologyNeurologicNeuronsNorepinephrineParkinson DiseaseParticipantPeripheralPhysiologyPlayPostdoctoral FellowRegulationResearchResearch PersonnelResortRewardsRoleSchizophreniaScientistSnowSourceStressStructureSubstance abuse problemSynapsesSystemTechniquesVermontWomanaddictionbasegraduate studenthuman diseaseinnovationmeetingsnervous system disorderneuropsychiatrynovelplanetary Atmosphereprogramspsychologicpublic health relevancereceptorresponsesymposiumtransmission process
项目摘要
DESCRIPTION (provided by applicant): The 2013 GRC/GRS Seminar on Catecholamines will take place at Mount Snow Resort, in West Dover, Vermont. August 10 - 16, 2013. This conference is held every other year; it is an ideal forum for exploring new developments in the field of catecholamines. It is also an excellent opportunity for junior investigators and trainees o interact with established investigators in a relaxed atmosphere. The evaluations of recent conferences highlight the strong impact this meeting typically has on emerging as well as established scientists. As the funds allocated by the Gordon Conference organization are limited, we are requesting funding from other sources. We are hoping that the results of our requests enable us to support speakers and discussion leaders as well as a large number of junior investigators to participate in the meeting. The conference includes two plenary talks, by Dr. Roy Wise and Dr. Susan Sesack. The preliminary program includes a large number of junior scientists and women, and the sessions planned include: 1) Catecholamines and Stress, 2) Catecholamines and Neurological Disorders, 3) Catecholamines in Substance Abuse, 4) Synaptic Regulation of Catecholaminergic Transmission, 5) Catecholamines Receptors, 6) Circuit-level Regulation of Catecholamine Function, 7) Economic Decision Making, 8) Catecholamines and Cognition and 9) Catecholamines Transporters. The themes covered in the 2013 Gordon Conference on Catecholamines are highly relevant to understanding the neurobiological bases of drug addiction and a variety of neurological and neuropsychiatric disorders including schizophrenia, affective disorders, bipolar disorder, OCD, and Parkinson's disease. This forum will provide a unique opportunity to discuss recent advances in the understanding of how catecholamine systems may contribute to the pathophysiology and treatment of those conditions. The fact that a large proportion of the participants are junior investigators and a significant number will be graduate students and postdocs ensure that this conference may have an impact on how future generations of neuroscientists view these issues.
描述(由申请人提供):2013年GRC/GRS研讨会的儿茶酚胺将在山雪度假村,在西多佛,佛蒙特州。2013年8月10日至16日。该会议每隔一年举行一次;它是探索儿茶酚胺领域新发展的理想论坛。这也是初级调查员和受训人员在轻松的气氛中与资深调查员互动的绝佳机会。对最近会议的评价突出表明,这次会议通常对新兴科学家和老牌科学家产生强烈影响。由于戈登会议组织分配的资金有限,我们正在请求其他来源提供资金。我们希望,我们的请求的结果使我们能够支持发言者和讨论领导人以及大量初级调查员参加会议。会议包括两个全体会议,由罗伊·怀斯博士和苏珊·塞萨克博士。初步方案包括大量的初级科学家和妇女,计划的会议包括:1)儿茶酚胺和应激,2)儿茶酚胺和神经障碍,3)物质滥用中的儿茶酚胺,4)儿茶酚胺能传递的突触调节,5)儿茶酚胺受体,6)儿茶酚胺功能的回路水平调节,7)经济决策,8)儿茶酚胺和认知以及9)儿茶酚胺转运蛋白。2013年戈登会议上所涉及的主题与理解药物成瘾的神经生物学基础以及各种神经和神经精神障碍(包括精神分裂症、情感障碍、双相情感障碍、强迫症和帕金森病)高度相关。本次论坛将提供一个独特的机会,讨论在了解如何儿茶酚胺系统可能有助于这些条件的病理生理学和治疗的最新进展。事实上,很大一部分参与者是初级研究人员,相当多的人将是研究生和博士后,确保这次会议可能会对未来几代神经科学家如何看待这些问题产生影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul E. M. Phillips其他文献
Making risk-takers settle
让冒险者安顿下来
- DOI:
10.1038/nature17314 - 发表时间:
2016-03-23 - 期刊:
- 影响因子:48.500
- 作者:
Nick G. Hollon;Paul E. M. Phillips - 通讯作者:
Paul E. M. Phillips
Calculating utility: preclinical evidence for cost–benefit analysis by mesolimbic dopamine
- DOI:
10.1007/s00213-006-0626-6 - 发表时间:
2006-11-22 - 期刊:
- 影响因子:3.300
- 作者:
Paul E. M. Phillips;Mark E. Walton;Thomas C. Jhou - 通讯作者:
Thomas C. Jhou
Paul E. M. Phillips的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul E. M. Phillips', 18)}}的其他基金
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10215470 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10399567 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10612394 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10035032 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking
在吸毒和寻求药物调节中,阶段性多巴胺对偶然和非偶然药物线索的直径变化
- 批准号:
9230365 - 财政年份:2015
- 资助金额:
$ 2.52万 - 项目类别:
8/8 NADIA UO1 Adolescent Alcohol and Decision Making
8/8 NADIA UO1 青少年酒精与决策
- 批准号:
9762555 - 财政年份:2015
- 资助金额:
$ 2.52万 - 项目类别:
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking
在吸毒和寻求药物调节中,阶段性多巴胺对偶然和非偶然药物线索的直径变化
- 批准号:
8912638 - 财政年份:2015
- 资助金额:
$ 2.52万 - 项目类别:
Contribution of dopamine to risk attitude across the lifespan
多巴胺对整个生命周期风险态度的贡献
- 批准号:
8413188 - 财政年份:2012
- 资助金额:
$ 2.52万 - 项目类别:
Contribution of dopamine to risk attitude across the lifespan
多巴胺对整个生命周期风险态度的贡献
- 批准号:
8733509 - 财政年份:2012
- 资助金额:
$ 2.52万 - 项目类别:
Contribution of dopamine to risk attitude across the lifespan
多巴胺对整个生命周期风险态度的贡献
- 批准号:
8549099 - 财政年份:2012
- 资助金额:
$ 2.52万 - 项目类别:
相似海外基金
Investigating how TRAF1 Controls Inflammasome Activation in Animal Disease Models of Inflammatory Arthritis and Peritonitis
研究 TRAF1 如何控制炎症性关节炎和腹膜炎动物疾病模型中的炎症小体激活
- 批准号:
449429 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Studentship Programs
Establishment of animal disease models for intractable pediatric diseases due to defects of RNA metabolism and development of new therapeutics
RNA代谢缺陷引起的儿科疑难疾病动物模型的建立及新疗法的开发
- 批准号:
20H03644 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of type 2 diabetes susceptibility genes using animal disease models
利用动物疾病模型对2型糖尿病易感基因进行功能分析
- 批准号:
18K08466 - 财政年份:2018
- 资助金额:
$ 2.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cell therapy of adipocytes derived from human iPS cells using cellcontainers and animal disease models
使用细胞容器和动物疾病模型对源自人类 iPS 细胞的脂肪细胞进行细胞治疗
- 批准号:
24659444 - 财政年份:2012
- 资助金额:
$ 2.52万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of genes involved in the pathogenesis of the arthritis using animal disease models..
使用动物疾病模型分析涉及关节炎发病机制的基因。
- 批准号:
17500284 - 财政年份:2005
- 资助金额:
$ 2.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ESTABLISHMENT OF THE DEVELOPING AND SUPPLING SYSTEMS FOR NEW ANIMAL,DISEASE MODELS FROM SUBSPECIES OF THE MOUSE
小鼠亚种新动物、疾病模型的开发和供应体系的建立
- 批准号:
07556128 - 财政年份:1995
- 资助金额:
$ 2.52万 - 项目类别:
Grant-in-Aid for Scientific Research (A)














{{item.name}}会员




